Document and Entity Information
Document and Entity Information - shares | 6 Months Ended | |
Jun. 30, 2024 | Jul. 29, 2024 | |
Document and Entity Information | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Document Period End Date | Jun. 30, 2024 | |
Securities Act File Number | 000-30941 | |
Entity Registrant Name | AXCELIS TECHNOLOGIES INC | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 34-1818596 | |
Entity Address, Address Line One | 108 Cherry Hill Drive | |
Entity Address, City or Town | Beverly | |
Entity Address, State or Province | MA | |
Entity Address, Postal Zip Code | 01915 | |
City Area Code | 978 | |
Local Phone Number | 787-4000 | |
Title of 12(b) Security | Common Stock, $0.001 par value | |
Trading Symbol | ACLS | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 32,617,587 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2024 | |
Document Fiscal Period Focus | Q2 | |
Entity Central Index Key | 0001113232 | |
Amendment Flag | false |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Revenue: | ||||
Total revenue | $ 256,512 | $ 273,970 | $ 508,883 | $ 527,990 |
Cost of revenue: | ||||
Total cost of revenue | 144,103 | 154,267 | 280,423 | 304,268 |
Gross profit | 112,409 | 119,703 | 228,460 | 223,722 |
Operating expenses: | ||||
Research and development | 25,786 | 24,130 | 51,448 | 47,903 |
Sales and marketing | 17,230 | 15,537 | 34,675 | 29,681 |
General and administrative | 16,583 | 16,328 | 32,988 | 31,073 |
Total operating expenses | 59,599 | 55,995 | 119,111 | 108,657 |
Income from operations | 52,810 | 63,708 | 109,349 | 115,065 |
Other income (expense): | ||||
Interest income | 6,051 | 4,307 | 11,566 | 8,243 |
Interest expense | (1,339) | (1,349) | (2,684) | (2,702) |
Other, net | (257) | (2,050) | (1,968) | (3,088) |
Total other income | 4,455 | 908 | 6,914 | 2,453 |
Income before income taxes | 57,265 | 64,616 | 116,263 | 117,518 |
Income tax provision | 6,399 | 3,037 | 13,803 | 8,242 |
Net income | $ 50,866 | $ 61,579 | $ 102,460 | $ 109,276 |
Net income per share: | ||||
Basic | $ 1.56 | $ 1.88 | $ 3.14 | $ 3.34 |
Diluted | $ 1.55 | $ 1.86 | $ 3.12 | $ 3.29 |
Shares used in computing net income per share: | ||||
Basic weighted average shares of common stock | 32,598 | 32,775 | 32,618 | 32,759 |
Diluted weighted average shares of common stock | 32,771 | 33,189 | 32,848 | 33,237 |
Product | ||||
Revenue: | ||||
Total revenue | $ 245,380 | $ 265,673 | $ 488,798 | $ 511,680 |
Cost of revenue: | ||||
Total cost of revenue | 134,759 | 146,741 | 262,670 | 289,512 |
Services | ||||
Revenue: | ||||
Total revenue | 11,132 | 8,297 | 20,085 | 16,310 |
Cost of revenue: | ||||
Total cost of revenue | $ 9,344 | $ 7,526 | $ 17,753 | $ 14,756 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Consolidated Statements of Comprehensive Income | ||||
Net income | $ 50,866 | $ 61,579 | $ 102,460 | $ 109,276 |
Other comprehensive loss: | ||||
Foreign currency translation adjustments | (913) | (1,011) | (2,644) | (961) |
Amortization of actuarial net gain and other adjustments from pension plan, net of tax | 5 | 10 | ||
Total other comprehensive loss | (908) | (1,011) | (2,634) | (961) |
Comprehensive income | $ 49,958 | $ 60,568 | $ 99,826 | $ 108,315 |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Jun. 30, 2024 | Dec. 31, 2023 |
Current assets: | ||
Cash and cash equivalents | $ 145,166 | $ 167,297 |
Short-Term Investments | 403,143 | 338,851 |
Accounts receivable, net | 188,080 | 217,964 |
Inventories, net | 283,090 | 306,482 |
Prepaid income taxes | 4,107 | |
Prepaid expenses and other current assets | 54,741 | 49,397 |
Total current assets | 1,078,327 | 1,079,991 |
Property, plant and equipment, net | 52,417 | 53,971 |
Operating lease assets | 28,918 | 30,716 |
Finance lease assets, net | 15,989 | 16,632 |
Long-term restricted cash | 6,651 | 6,654 |
Deferred income taxes | 55,441 | 53,428 |
Other assets | 50,662 | 40,575 |
Total assets | 1,288,405 | 1,281,967 |
Current liabilities: | ||
Accounts payable | 45,782 | 54,400 |
Accrued compensation | 16,069 | 31,445 |
Warranty | 14,502 | 14,098 |
Income taxes | 6,164 | |
Deferred revenue | 148,390 | 164,677 |
Current portion of finance lease obligation | 1,452 | 1,511 |
Other current liabilities | 17,984 | 12,834 |
Total current liabilities | 244,179 | 285,129 |
Long-term finance lease obligation | 43,004 | 43,674 |
Long-term deferred revenue | 25,621 | 46,208 |
Other long-term liabilities | 40,653 | 42,074 |
Total liabilities | 353,457 | 417,085 |
Commitments and contingencies (Note 17) | ||
Stockholders' equity: | ||
Common stock, $0.001 par value, 75,000 shares authorized; 32,617 shares issued and outstanding at June 30, 2024; 32,685 shares issued and outstanding at December 31, 2023 | 33 | 33 |
Additional paid-in capital | 542,677 | 547,189 |
Retained earnings | 396,718 | 319,506 |
Accumulated other comprehensive loss | (4,480) | (1,846) |
Total stockholders' equity | 934,948 | 864,882 |
Total liabilities and stockholders' equity | $ 1,288,405 | $ 1,281,967 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - $ / shares shares in Thousands | Jun. 30, 2024 | Dec. 31, 2023 |
Consolidated Balance Sheets | ||
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 75,000 | 75,000 |
Common stock, shares issued | 32,617 | 32,685 |
Common stock, shares outstanding | 32,617 | 32,685 |
Consolidated Statements of Stoc
Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands | Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive (Loss) | Total |
Balance at Dec. 31, 2022 | $ 33 | $ 550,299 | $ 118,892 | $ (1,968) | $ 667,256 |
Balance (in shares) at Dec. 31, 2022 | 32,775 | ||||
Increase (Decrease) in Stockholders' Equity | |||||
Net income | 47,697 | 47,697 | |||
Foreign currency translation adjustments | 50 | 50 | |||
Exercise of stock options (in shares) | 2 | ||||
Exercise of stock options | 25 | 25 | |||
Issuance of common stock on restricted stock units, net of shares withheld | (3,907) | (3,907) | |||
Issuance of common stock on restricted stock units, net of shares withheld (in shares) | 56 | ||||
Stock-based compensation expense | 3,199 | 3,199 | |||
Repurchase of common stock | (1,924) | (10,575) | (12,499) | ||
Repurchase of common stock (in shares) | (107) | ||||
Balance at Mar. 31, 2023 | $ 33 | 547,692 | 156,014 | (1,918) | 701,821 |
Balance (in shares) at Mar. 31, 2023 | 32,726 | ||||
Balance at Dec. 31, 2022 | $ 33 | 550,299 | 118,892 | (1,968) | 667,256 |
Balance (in shares) at Dec. 31, 2022 | 32,775 | ||||
Increase (Decrease) in Stockholders' Equity | |||||
Net income | 109,276 | ||||
Foreign currency translation adjustments | (961) | ||||
Balance at Jun. 30, 2023 | $ 33 | 540,120 | 206,813 | (2,929) | 744,037 |
Balance (in shares) at Jun. 30, 2023 | 32,836 | ||||
Balance at Mar. 31, 2023 | $ 33 | 547,692 | 156,014 | (1,918) | 701,821 |
Balance (in shares) at Mar. 31, 2023 | 32,726 | ||||
Increase (Decrease) in Stockholders' Equity | |||||
Net income | 61,579 | 61,579 | |||
Foreign currency translation adjustments | (1,011) | (1,011) | |||
Issuance of stock under Employee Stock Purchase Plan | 957 | 957 | |||
Issuance of stock under Employee Stock Purchase Plan (in shares) | 6 | ||||
Issuance of common stock on restricted stock units, net of shares withheld | (11,558) | (11,558) | |||
Issuance of common stock on restricted stock units, net of shares withheld (in shares) | 199 | ||||
Stock-based compensation expense | 4,749 | 4,749 | |||
Repurchase of common stock | (1,720) | (10,780) | (12,500) | ||
Repurchase of common stock (in shares) | (95) | ||||
Balance at Jun. 30, 2023 | $ 33 | 540,120 | 206,813 | (2,929) | 744,037 |
Balance (in shares) at Jun. 30, 2023 | 32,836 | ||||
Balance at Dec. 31, 2023 | $ 33 | 547,189 | 319,506 | (1,846) | 864,882 |
Balance (in shares) at Dec. 31, 2023 | 32,685 | ||||
Increase (Decrease) in Stockholders' Equity | |||||
Net income | 51,595 | 51,595 | |||
Foreign currency translation adjustments | (1,731) | (1,731) | |||
Change in pension obligation, net of tax | 5 | 5 | |||
Issuance of common stock on restricted stock units, net of shares withheld | (2,699) | (2,699) | |||
Issuance of common stock on restricted stock units, net of shares withheld (in shares) | 42 | ||||
Stock-based compensation expense | 4,690 | 4,690 | |||
Repurchase of common stock | (2,201) | (12,798) | (14,999) | ||
Repurchase of common stock (in shares) | (122) | ||||
Balance at Mar. 31, 2024 | $ 33 | 546,979 | 358,303 | (3,572) | 901,743 |
Balance (in shares) at Mar. 31, 2024 | 32,605 | ||||
Balance at Dec. 31, 2023 | $ 33 | 547,189 | 319,506 | (1,846) | 864,882 |
Balance (in shares) at Dec. 31, 2023 | 32,685 | ||||
Increase (Decrease) in Stockholders' Equity | |||||
Net income | 102,460 | ||||
Foreign currency translation adjustments | (2,644) | ||||
Change in pension obligation, net of tax | 10 | ||||
Balance at Jun. 30, 2024 | $ 33 | 542,677 | 396,718 | (4,480) | 934,948 |
Balance (in shares) at Jun. 30, 2024 | 32,617 | ||||
Balance at Mar. 31, 2024 | $ 33 | 546,979 | 358,303 | (3,572) | 901,743 |
Balance (in shares) at Mar. 31, 2024 | 32,605 | ||||
Increase (Decrease) in Stockholders' Equity | |||||
Net income | 50,866 | 50,866 | |||
Foreign currency translation adjustments | (913) | (913) | |||
Change in pension obligation, net of tax | 5 | 5 | |||
Issuance of stock under Employee Stock Purchase Plan | 1,242 | 1,242 | |||
Issuance of stock under Employee Stock Purchase Plan (in shares) | 10 | ||||
Issuance of common stock on restricted stock units, net of shares withheld | (8,468) | (8,468) | |||
Issuance of common stock on restricted stock units, net of shares withheld (in shares) | 143 | ||||
Stock-based compensation expense | 5,469 | 5,469 | |||
Repurchase of common stock | (2,545) | (12,451) | (14,996) | ||
Repurchase of common stock (in shares) | (141) | ||||
Balance at Jun. 30, 2024 | $ 33 | $ 542,677 | $ 396,718 | $ (4,480) | $ 934,948 |
Balance (in shares) at Jun. 30, 2024 | 32,617 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2024 | Jun. 30, 2023 | |
Cash flows from operating activities | ||
Net income | $ 102,460 | $ 109,276 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation and amortization | 7,636 | 6,258 |
Deferred income taxes | (2,013) | (7,413) |
Stock-based compensation expense | 10,159 | 7,948 |
Provision for doubtful accounts | (459) | |
Provision for excess and obsolete inventory | 2,846 | 2,494 |
Accretion of discounts and premiums on marketable securities | (6,623) | (5,753) |
Currency loss on foreign denominated transactions | 11,505 | 5,717 |
Changes in operating assets and liabilities: | ||
Accounts receivable | 25,009 | 8,173 |
Inventories | 12,951 | (63,294) |
Prepaid expenses and other current assets | (5,849) | (5,095) |
Accounts payable and other current liabilities | (18,541) | (18,266) |
Deferred revenue | (35,957) | 28,075 |
Income taxes | (8,391) | 2,324 |
Other assets and liabilities | (12,443) | (3,170) |
Net cash provided by operating activities | 82,290 | 67,274 |
Cash flows from investing activities | ||
Expenditures for property, plant and equipment and capitalized software | (3,624) | (5,202) |
Purchase of short-term investments | (249,015) | (188,943) |
Maturities of short-term investments | 191,345 | 120,907 |
Net cash used in investing activities | (61,294) | (73,238) |
Cash flows from financing activities | ||
Net settlement on restricted stock grants | (11,167) | (15,465) |
Repurchase of common stock | (29,995) | (24,999) |
Proceeds from Employee Stock Purchase Plan purchases | 1,242 | 957 |
Principal payments on finance lease obligation | (736) | (598) |
Proceeds from exercise of stock options | 25 | |
Net cash used in financing activities | (40,656) | (40,080) |
Effect of exchange rate changes on cash and cash equivalents | (2,474) | (1,147) |
Net decrease in cash, cash equivalents and restricted cash | (22,134) | (47,191) |
Cash, cash equivalents and restricted cash at beginning of period | 173,951 | 186,347 |
Cash, cash equivalents and restricted cash at end of period | $ 151,817 | $ 139,156 |
Nature of Business
Nature of Business | 6 Months Ended |
Jun. 30, 2024 | |
Nature of Business | |
Nature of Business | Note 1. Nature of Business Axcelis Technologies, Inc. (“Axcelis” or the “Company”) was incorporated in Delaware in 1995 and is a producer of ion implantation equipment used in the fabrication of semiconductor chips in the United States, Europe and Asia. In addition, we provide extensive worldwide aftermarket service and support, including spare parts, equipment upgrades, used equipment, and maintenance services to the semiconductor industry. The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments which are of a normal recurring nature and considered necessary for a fair presentation of these financial statements have been included. Operating results for the interim periods presented are not necessarily indicative of the results that may be expected for other interim periods or for the year as a whole. The balance sheet at December 31, 2023 has been derived from the audited consolidated financial statements at that date but does not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. As of June 30, 2024, there have been no material changes in the Company’s significant accounting policies, other than with respect to the Company’s accounting policy for derivative financial instruments, which it had not held in prior periods, as described in Note 2 below. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities and Exchange Commission (the “SEC”) on February 23, 2024, as amended by Amendment No. 1 thereto, filed with the SEC on February 28, 2024 (as so amended, the “2023 Form 10-K”). |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 6 Months Ended |
Jun. 30, 2024 | |
Summary of Significant Accounting Policies | |
Summary of Significant Accounting Policies | Note 2. Significant Accounting Policies Derivative instruments We do not offset fair value amounts of derivative instruments. We do not use derivative instruments for speculative purposes. |
Stock-Based Compensation
Stock-Based Compensation | 6 Months Ended |
Jun. 30, 2024 | |
Stock-Based Compensation | |
Stock-Based Compensation | Note 3. Stock-Based Compensation We maintain the Axcelis Technologies, Inc. 2012 Equity Incentive Plan, as amended (the “2012 Equity Plan”), which became effective on May 2, 2012, and permits the issuance of options, restricted stock, restricted stock units (“RSUs”) and performance awards to selected employees, directors, and consultants of the Company. The 2012 Equity Plan is more fully described in Note 13 to the consolidated financial statements in our 2023 Form 10-K. We recognized stock-based compensation expense of $5.5 million and $4.7 million for the three-month periods ended June 30, 2024 and 2023, respectively. We recognized stock-based compensation expense of $10.2 million and $7.9 million for the six-month periods ended June 30, 2024 and 2023, respectively. These amounts include compensation expense related to RSUs, non-qualified stock options, and stock to be issued to participants under the 2020 Employee Stock Purchase Plan (the “2020 ESPP”). In the three-month periods ended June 30, 2024 and 2023, respectively, we issued 0.2 million shares of common stock upon vesting of RSUs granted under the 2012 Equity Plan and purchases under the 2020 ESPP. In the three-month period ended June 30, 2024 and 2023, we received proceeds of $1.2 million and $1.0 million, respectively, from purchases under the 2020 ESPP. In the six-month period ended June 30, 2024 and 2023, we issued 0.2 million and 0.3 million shares of common stock, respectively, upon vesting of RSUs granted under the 2012 Equity Plan and purchases under the 2020 ESPP. In the six-month period ended June 30, 2024 and 2023, we received proceeds of $1.2 million and $1.0 million, respectively, in connection with purchases under the 2020 ESPP. |
Leases
Leases | 6 Months Ended |
Jun. 30, 2024 | |
Leases | |
Leases | Note 4. Leases We have operating leases for manufacturing, office space, warehouse space, computer and office equipment and vehicles used in our business operations. We have a finance lease in relation to the 2015 sale-leaseback of our corporate headquarters in Beverly, Massachusetts. We review all agreements to determine if the agreement contains a lease component. An agreement contains a lease component if it provides for the use of a specific physical space or a specific physical item. We recognize operating lease obligations under Accounting Standards Codification Topic 842, Leases options to renew one June 30, December 31, Leases Classification 2024 2023 Assets (in thousands) Operating leases Operating lease assets $ 28,918 $ 30,716 Finance lease Finance lease assets* 15,989 16,632 Total leased assets $ 44,907 $ 47,348 Liabilities Current Operating Other current liabilities $ 4,637 $ 4,978 Finance Current portion of finance lease obligation 1,452 1,511 Non-current Operating Other long-term liabilities 24,329 25,724 Finance Finance lease obligation 43,004 43,674 Total lease liabilities $ 73,422 $ 75,887 *Finance lease assets are recorded net of accumulated depreciation of $46.9 million and include $0.6 million of prepaid financing costs as of June 30, 2024. Finance lease assets are recorded net of accumulated depreciation of $46.4 million and include $0.6 million of prepaid financing costs as of December 31, 2023. Three months ended Six months ended June 30, June 30, Lease cost Classification 2024 2023 2024 2023 Operating lease cost (in thousands) Product / services* Cost of revenue $ 1,694 $ 1,821 $ 3,522 $ 3,287 Research and development Operating expenses 203 137 326 243 Sales and marketing* Operating expenses 451 417 902 813 General and administrative* Operating expenses 337 239 532 515 Total operating lease cost $ 2,685 $ 2,614 $ 5,282 $ 4,858 Finance lease cost Depreciation of leased assets Cost of revenue, Research and development, Sales and marketing and General and administrative $ 321 $ 318 $ 643 $ 637 Interest on lease liabilities Interest expense 1,187 1,223 2,384 2,454 Total finance lease cost $ 1,508 $ 1,541 $ 3,027 $ 3,091 Total lease cost $ 4,193 $ 4,155 $ 8,309 $ 7,949 * Product / services, sales and marketing and general and administrative expense also includes short-term lease and variable lease costs of approximately $0.7 million and $1.3 million for the three and six months ended June 30, 2024, respectively, and includes short-term lease and variable lease costs of approximately $0.5 million and $1.0 million for the three and six months ended June 30, 2023, respectively. one Finance Operating Total Maturity of Lease Liabilities Leases Leases Leases (in thousands) 2024 $ 3,132 $ 3,740 $ 6,872 2025 5,930 6,113 12,043 2026 6,008 4,448 10,456 2027 6,128 2,863 8,991 2028 6,251 1,959 8,210 Thereafter 55,336 23,205 78,541 Total lease payments $ 82,785 $ 42,328 $ 125,113 Less interest portion* (38,329) (13,362) (51,691) Finance lease and operating lease obligations $ 44,456 $ 28,966 $ 73,422 * Finance lease interest calculated using the implied interest rate; operating lease interest calculated using estimated corporate borrowing rate. The table above does not include options to renew lease terms that are not reasonably certain of being exercised. June 30, Lease term and discount rate 2024 Weighted-average remaining lease term (years): Operating leases 11.5 Finance leases 12.6 Weighted-average discount rate: Operating leases 5.5% Finance leases 10.5% Six months ended June 30, Cash paid for amounts included in the measurement of lease liabilities 2024 2023 (in thousands) Operating cash outflows from operating leases $ 5,282 $ 4,858 Operating cash outflows from finance leases 2,384 2,454 Financing cash outflows from finance leases 736 598 Operating lease assets obtained in exchange for operating lease liabilities 825 23,289 Finance lease assets obtained in exchange for new finance lease liabilities — — |
Revenue
Revenue | 6 Months Ended |
Jun. 30, 2024 | |
Revenue | |
Revenue | Note 5. Revenue Three months ended Six months ended June 30, June 30, 2024 2023 2024 2023 (in thousands) Systems $ 198,645 $ 215,174 $ 394,076 $ 410,372 Aftermarket 57,867 58,796 114,807 117,618 Total Revenue $ 256,512 $ 273,970 $ 508,883 $ 527,990 Three months ended Six months ended June 30, June 30, 2024 2023 2024 2023 (in thousands) North America $ 34,373 $ 37,918 $ 79,876 $ 83,084 Asia Pacific 196,159 205,941 384,376 397,044 Europe 25,980 30,111 44,631 47,862 Total Revenue $ 256,512 $ 273,970 $ 508,883 $ 527,990 June 30, December 31, 2024 2023 (in thousands) Contract liabilities $ 174,011 $ 210,885 Three months ended Six months ended June 30, June 30, 2024 2023 2024 2023 (in thousands) Balance, beginning of the period $ 208,418 $ 201,725 $ 210,885 $ 154,777 Deferral of revenue* 19,625 34,977 55,227 107,556 Recognition of deferred revenue (54,032) (54,162) (92,101) (79,793) Balance, end of the period $ 174,011 $ 182,540 $ 174,011 $ 182,540 * Amount is net of a reclassification of |
Receivables and Allowances for
Receivables and Allowances for Credit Losses | 6 Months Ended |
Jun. 30, 2024 | |
Receivables and Allowances for Credit Losses | |
Receivables and Allowances for Credit Losses | Note 6. Receivables and Allowances for Credit Losses All trade receivables are reported on the consolidated balance sheets at their amortized cost adjusted for any write-offs and net of allowances for credit losses. We maintain an allowance for credit losses, which represents an estimate of expected losses over the remaining contractual life of our receivables, considering current market conditions and estimates for supportable forecasts when appropriate. The estimate is a result of our ongoing assessments and evaluations of collectability, historical loss experience, and future expectations in estimating credit losses in our receivable portfolio. We use historical loss experience rates and apply them to a related aging analysis while also considering customer and/or economic risk where appropriate. Determination of the proper amount of allowances requires management to exercise judgment about the timing, frequency and severity of credit losses that could materially affect the provision for credit losses and, as a result, net earnings. The allowance takes into consideration numerous quantitative and qualitative factors that include receivable type, historical loss experience, loss migration, delinquency trends, collection experience, current economic conditions, trade restrictions, estimates for supportable forecasts, when appropriate, and credit risk characteristics. We evaluate the credit risk of the customer when extending credit based on a combination of financial and qualitative factors that may affect our customers’ ability to pay. These factors may include the customer’s financial condition, past payment experience, and credit bureau report, as well as the value of the underlying collateral. Management performs detailed reviews of our receivables on a quarterly basis to assess the adequacy of the allowances and to determine if any impairment has occurred. Amounts determined to be uncollectable are charged directly against the allowances, while amounts recovered on previously written-off accounts increase the allowances. Changes to the allowances for credit losses are maintained through adjustments to the provision for credit losses, which are charged to current period earnings. We did not incur any credit losses or recoveries for the three month period ended June 30, 2024. We recorded $0.5 million of recovery of bad debt expense for the six-month period ended June 30, 2024. We did not have any allowance or incur any credit losses or recoveries for the six-month period ended June 30, 2023. As of both June 30, 2024 and 2023, we had no provision for credit losses. |
Computation of Net Earnings per
Computation of Net Earnings per Share | 6 Months Ended |
Jun. 30, 2024 | |
Computation of Net Earnings per Share | |
Computation of Net Earnings per Share | Note 7. Computation of Net Earnings per Share Basic earnings per share is computed by dividing income available to common stockholders (the numerator) by the weighted-average number of shares of common stock outstanding (the denominator) for the period. The computation of diluted earnings per share is similar to basic earnings per share, except that the denominator is increased by the number of additional shares of common stock that would have been outstanding if the potentially dilutive shares of common stock issuable on exercise of stock options and vesting of RSUs had been issued, calculated using the treasury stock method. The components of net earnings per share are as follows: Three months ended Six months ended June 30, June 30, 2024 2023 2024 2023 (in thousands, except per share amounts) Net income available to common stockholders $ 50,866 $ 61,579 $ 102,460 $ 109,276 Weighted average shares of common stock outstanding used in computing basic income per share 32,598 32,775 32,618 32,759 Incremental options and RSUs 173 414 230 478 Weighted average shares of common stock used in computing diluted net income per share 32,771 33,189 32,848 33,237 Net income per share Basic $ 1.56 $ 1.88 $ 3.14 $ 3.34 Diluted $ 1.55 $ 1.86 $ 3.12 $ 3.29 Diluted weighted average shares of common stock outstanding does not include 22,983 and 770 common equivalent shares issuable with respect to outstanding equity awards for the three-month periods ended June 30, 2024 and 2023, respectively, or 20,639 and 387 common equivalent shares issuable with respect to outstanding equity awards for the six-month periods ended June 30, 2024 and 2023, respectively, as their effect would have been anti-dilutive. |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Loss | 6 Months Ended |
Jun. 30, 2024 | |
Accumulated Other Comprehensive Loss | |
Accumulated Other Comprehensive Loss | Note 8. Accumulated Other Comprehensive Loss The following table presents the changes in accumulated other comprehensive loss, net of tax, by component, for the six months ended June 30, 2024: Foreign Defined benefit currency pension plan Total (in thousands) Balance at December 31, 2023 $ (1,956) $ 110 $ (1,846) Other comprehensive loss and pension reclassification (2,644) 10 (2,634) Balance at June 30, 2024 $ (4,600) $ 120 $ (4,480) |
Cash, cash equivalents and rest
Cash, cash equivalents and restricted cash | 6 Months Ended |
Jun. 30, 2024 | |
Cash, cash equivalents and restricted cash | |
Cash, cash equivalents and restricted cash | Note 9. Cash, cash equivalents and restricted cash The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets to the total of the amounts shown in the statement of cash flows: June 30, December 31, 2024 2023 (in thousands) Cash and cash equivalents $ 145,166 $ 167,297 Long-term restricted cash 6,651 6,654 Total cash, cash equivalents and restricted cash $ 151,817 $ 173,951 As of June 30, 2024, we had $6.7 million in restricted cash representing the total of (i) a $5.9 million cash collateral relating to our lease for our headquarters in Beverly, Massachusetts, (ii) a $0.7 million letter of credit relating to workers’ compensation insurance and (iii) a $0.1 million deposit relating to customs activity. See Note 13 for further discussion on the $5.9 million cash collateral. |
Inventories, net
Inventories, net | 6 Months Ended |
Jun. 30, 2024 | |
Inventories, net | |
Inventories, net | Note 10. Inventories, net The components of inventories are as follows: June 30, December 31, 2024 2023 (in thousands) Raw materials $ 220,910 $ 231,200 Work in process 40,481 45,373 Finished goods (completed systems) 21,699 29,909 Inventories, net $ 283,090 $ 306,482 When recorded, inventory reserves reduce the carrying value of inventories to their net realizable value. We establish inventory reserves when conditions exist that indicate inventory may be in excess of anticipated demand or is obsolete based upon assumptions about future demand for our products or market conditions. We regularly evaluate the ability to realize the value of inventories based on a combination of factors including the following: forecasted sales or usage, estimated product end of life dates, estimated current and future market value and new product introductions. Purchasing and usage alternatives are also explored to mitigate inventory exposure. |
Product Warranty
Product Warranty | 6 Months Ended |
Jun. 30, 2024 | |
Product Warranty | |
Product Warranty | Note 11. Product Warranty We generally offer a one-year warranty for all of our systems, the terms and conditions of which vary depending upon the product sold. For all systems sold, we accrue a liability for the estimated cost of standard warranty at the time of system shipment and, if applicable, defer the portion of systems revenue attributable to non-standard warranty. Costs for non-standard warranty are expensed as incurred. Factors that affect our warranty liability include the number of installed units, historical and anticipated product failure rates, material usage and service labor costs. We periodically assess the adequacy of our recorded liability and adjust the amount as necessary. The changes in our standard product warranty liability are as follows: Six months ended June 30, 2024 2023 (in thousands) Balance at January 1 (beginning of year) $ 16,757 $ 10,487 Warranties issued during the period 5,755 5,616 Settlements made during the period (5,653) (4,834) Changes in estimate of liability for pre-existing warranties during the period (444) 1,552 Balance at June 30 (end of period) $ 16,415 $ 12,821 Amount classified as current $ 14,502 $ 10,867 Amount classified as long-term (within other long-term liabilities) 1,913 1,954 Total warranty liability $ 16,415 $ 12,821 |
Fair Value Measurements
Fair Value Measurements | 6 Months Ended |
Jun. 30, 2024 | |
Fair Value Measurements | |
Fair Value Measurements | Note 12. Fair Value Measurements Fair value is defined as the price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. (a) Fair Value Hierarchy The accounting guidance for fair value measurement requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is as follows: Level 1 Level 2 Level 3 (b) Fair Value Measurements Our money market funds and short-term investments with initial maturities of three months or less are included in cash and cash equivalents in the consolidated balance sheets. Other investments that have a maturity of greater than three months but less than one year are included within short-term investments in the consolidated balance sheets. The following table sets forth our assets by level within the fair value hierarchy: June 30, 2024 Fair Value Measurements Level 1 Level 2 Level 3 Total (in thousands) Assets Cash equivalents and other short-term investments: Cash equivalents (money market funds, U.S. Government Securities and Agency Investments) $ 104,958 $ — $ — $ 104,958 Short-term investments (U.S. Government Securities and Agency Investments) 402,820 — — 402,820 Mark-to-market adjustment on forward exchange contracts — (323) — (323) Total $ 507,778 $ (323) $ — $ 507,455 December 31, 2023 Fair Value Measurements Level 1 Level 2 Level 3 Total (in thousands) Assets Cash equivalents and other short-term investments: Cash equivalents (money market funds, U.S. Government Securities and Agency Investments) $ 118,278 $ — $ — $ 118,278 Short-term investments (U.S. Government Securities and Agency Investments) 339,240 — — 339,240 Total $ 457,518 $ — $ — $ 457,518 (c) Other Financial Instruments The carrying amounts reflected in the consolidated balance sheets for accounts receivable, prepaid expenses, forward currency exchange contracts and other current assets and non-current assets, restricted cash, accounts payable and accrued expenses approximate fair value due to their short-term maturities. (d) Forward Currency Exchange Contracts Beginning in February 2024, we entered into forward currency exchange contracts to minimize the impact of foreign currency fluctuations on our earnings and cash flows. These contracts have month-to-month settlement dates. Any gains or losses on these contracts are reported within Other, net within our Consolidated Statement of Operations. Any open contracts at period end that have settlement dates within one month after the reported period end and any mark-to-market valuation adjustments related to these open contracts are recorded within the current asset or current liability account and any unrealized gain or loss recognized is recorded within Other, net within our Consolidated Statement of Operations. These contracts are measured at fair value using observable market inputs such as forward currency exchange rates and our counterparties’ credit risks. Based on these inputs, the derivative instruments are classified within Level 2 of the valuation hierarchy. At June 30, 2024, the recognized unrealized loss on these forward exchange contracts was approximately $323 thousand. Based on our continued ability to trade and enter into forward contracts, we consider the markets for our fair value instruments to be active. We evaluated the credit risk associated with the counterparties to these derivative instruments and determined that as of June 30, 2024, such credit risks have not had an adverse impact on the fair value of these instruments. |
Financing Arrangements
Financing Arrangements | 6 Months Ended |
Jun. 30, 2024 | |
Financing Arrangements | |
Financing Arrangements | Note 13. Financing Arrangements On January 30, 2015, we sold our corporate headquarters facility in Beverly, Massachusetts for $48.9 million. As part of the sale, we also entered into a 22-year lease agreement of our headquarters facility. This sale-leaseback is accounted for as a financing lease under generally accepted accounting principles and, as such, we have recorded a financing obligation of $44.5 million as of June 30, 2024. The associated lease payments include both an interest component and payment of principal, with the remaining liability being extinguished at the end of the original lease term. As of June 30, 2024, we had a security deposit of $5.9 million related to this lease in the form of a cash collateralized letter of credit issued with UBS Bank USA, which is classified as long-term restricted cash on our balance sheet at June 30, 2024. |
Income Taxes
Income Taxes | 6 Months Ended |
Jun. 30, 2024 | |
Income Taxes | |
Income Taxes | Note 14. Income Taxes Income tax expense was $6.4 million for the three months ended June 30, 2024, compared to $3.0 million for the three months ended June 30, 2023. The $3.4 million increase was primarily due to a decrease in stock compensation deduction. Income tax expense was $13.8 million for the six months ended June 30, 2024, compared to $8.2 million for the six months ended June 30, 2023. The increase was primarily due to a decrease in stock compensation deduction. The effective tax rate for the three and six months ended June 30, 2024 was less than the U.S. statutory rate of 21% due to a forecasted Foreign Derived Intangible Income deduction, Federal research and development tax credits and a favorable discrete item related to equity compensation that reduces the annual tax rate. The deferred income taxes of $55.4 million and $53.4 million as of June 30, 2024 and December 31, 2023, respectively, reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, as well as the tax effect of carryforwards. As of June 30, 2024, we have recorded a $11.3 million valuation allowance in the U.S. against certain tax credits due to the uncertainty of their realization. Realization of our net deferred tax assets is dependent on future taxable income. We believe it is more likely than not that such assets will be realized; however, ultimate realization could be impacted by market conditions and other variables not known or anticipated at this time. |
Concentration of Risk
Concentration of Risk | 6 Months Ended |
Jun. 30, 2024 | |
Concentration of Risk | |
Concentration of Risk | Note 15. Concentration of Risk For the three months ended June 30, 2024, one customer accounted for 11.5% of total revenue. For the three months ended June 30, 2023, no individual customer accounted for greater than ten percent of total revenue. For the six months ended June 30, 2024, no individual customer accounted for greater than ten percent of total revenue. For the six months ended June 30, 2023, two customers accounted for 11.6% and 11.1% of total revenue, respectively. At June 30, 2024, one customer accounted for 11.3% of accounts receivable. At December 31, 2023, one customer accounted for 12.2% of accounts receivable. |
Share Repurchase
Share Repurchase | 6 Months Ended |
Jun. 30, 2024 | |
Stockholders' Equity | |
Share Repurchase | Note 16. Share Repurchase In February 2022, our Board of Directors approved stock repurchases of up to $100 million of our common stock. In August 2023, our Board of Directors approved additional funding of $200 million for our stock repurchase program, to be available on full utilization of the $100 million repurchase funding approved in February 2022. During the six months ended June 30, 2024, we repurchased 0.3 million shares at an average cost of $114.07 per share. The timing and actual number of any additional shares to be repurchased under this program will depend on various factors including price, corporate and regulatory requirements, alternative investment opportunities and other market conditions. Repurchased shares are accounted for when the transaction is settled and returned to the status of authorized but unissued shares. Accordingly, on our balance sheet, the repurchase price is deducted from common stock par value and from additional paid-in capital for the excess over par value. If additional paid-in capital has been exhausted, the excess over par value is deducted from retained earnings. Direct costs incurred to acquire the shares are included in the total cost of the shares. |
Contingencies
Contingencies | 6 Months Ended |
Jun. 30, 2024 | |
Contingencies | |
Contingencies | Note 17. Contingencies (a) Litigation We are from time to time a party to litigation that arises in the normal course of our business operations. We are not presently a party to any litigation that we believe might have a material adverse effect on our business operations. (b) Indemnifications Our system sales agreements typically include provisions under which we agree to take certain actions, provide certain remedies and defend our customers against third-party claims of intellectual property infringement under specified conditions and indemnify customers against any damage and costs awarded in connection with such claims. We have not incurred any material costs as a result of such indemnifications and have not accrued any liabilities related to such obligations in the accompanying consolidated financial statements. |
Recent Accounting Guidance
Recent Accounting Guidance | 6 Months Ended |
Jun. 30, 2024 | |
Summary of Significant Accounting Policies | |
Recent Accounting Guidance | Note 18. Recent Accounting Guidance In November 2023 the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). ASU 2023-07 is intended to enhance disclosures for significant segment expenses for all public entities required to report segment information in accordance with ASC Topic 280, Segment Reporting (“ASC 280”). ASC 280 requires a public entity to report for each reportable segment a measure of segment profit or loss that its chief operating decision maker (“CODM”) uses to assess segment performance and to make decisions about resource allocations. ASU 2023-07 is intended to improve financial reporting by requiring disclosure of incremental segment information on an annual and interim basis for all public entities to enable investors to develop more useful financial analyses. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. A public entity should apply ASU 2023-07 retrospectively to all prior periods presented in the consolidated financial statements. We are currently evaluating the impact of ASU 2023-07 on our future consolidated financial statements and related disclosures. In December 2023 the FASB issued Accounting Standards Update 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 is intended to enhance the transparency and decision usefulness of income tax disclosures. ASU 2023-09 addresses investor requests for enhanced income tax information primarily through changes to the rate reconciliation and income taxes paid information. Early adoption is permitted. A public entity should apply ASU 2023-09 prospectively to all annual periods beginning after December 15, 2024. We are currently evaluating the impact of ASU 2023-09 on our future consolidated financial statements and related disclosures. |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Jun. 30, 2024 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 6 Months Ended |
Jun. 30, 2024 | |
Summary of Significant Accounting Policies | |
Derivative instruments | Derivative instruments We do not offset fair value amounts of derivative instruments. We do not use derivative instruments for speculative purposes. |
Leases (Tables)
Leases (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Leases | |
Schedule of operating and finance lease right-of-use assets and related lease obligations | June 30, December 31, Leases Classification 2024 2023 Assets (in thousands) Operating leases Operating lease assets $ 28,918 $ 30,716 Finance lease Finance lease assets* 15,989 16,632 Total leased assets $ 44,907 $ 47,348 Liabilities Current Operating Other current liabilities $ 4,637 $ 4,978 Finance Current portion of finance lease obligation 1,452 1,511 Non-current Operating Other long-term liabilities 24,329 25,724 Finance Finance lease obligation 43,004 43,674 Total lease liabilities $ 73,422 $ 75,887 *Finance lease assets are recorded net of accumulated depreciation of $46.9 million and include $0.6 million of prepaid financing costs as of June 30, 2024. Finance lease assets are recorded net of accumulated depreciation of $46.4 million and include $0.6 million of prepaid financing costs as of December 31, 2023. |
Schedule of lease costs | Three months ended Six months ended June 30, June 30, Lease cost Classification 2024 2023 2024 2023 Operating lease cost (in thousands) Product / services* Cost of revenue $ 1,694 $ 1,821 $ 3,522 $ 3,287 Research and development Operating expenses 203 137 326 243 Sales and marketing* Operating expenses 451 417 902 813 General and administrative* Operating expenses 337 239 532 515 Total operating lease cost $ 2,685 $ 2,614 $ 5,282 $ 4,858 Finance lease cost Depreciation of leased assets Cost of revenue, Research and development, Sales and marketing and General and administrative $ 321 $ 318 $ 643 $ 637 Interest on lease liabilities Interest expense 1,187 1,223 2,384 2,454 Total finance lease cost $ 1,508 $ 1,541 $ 3,027 $ 3,091 Total lease cost $ 4,193 $ 4,155 $ 8,309 $ 7,949 * Product / services, sales and marketing and general and administrative expense also includes short-term lease and variable lease costs of approximately $0.7 million and $1.3 million for the three and six months ended June 30, 2024, respectively, and includes short-term lease and variable lease costs of approximately $0.5 million and $1.0 million for the three and six months ended June 30, 2023, respectively. |
Schedule of future minimum operating and finance leases | Finance Operating Total Maturity of Lease Liabilities Leases Leases Leases (in thousands) 2024 $ 3,132 $ 3,740 $ 6,872 2025 5,930 6,113 12,043 2026 6,008 4,448 10,456 2027 6,128 2,863 8,991 2028 6,251 1,959 8,210 Thereafter 55,336 23,205 78,541 Total lease payments $ 82,785 $ 42,328 $ 125,113 Less interest portion* (38,329) (13,362) (51,691) Finance lease and operating lease obligations $ 44,456 $ 28,966 $ 73,422 * Finance lease interest calculated using the implied interest rate; operating lease interest calculated using estimated corporate borrowing rate. |
Schedule of weighted-average remaining lease term and discount rates | June 30, Lease term and discount rate 2024 Weighted-average remaining lease term (years): Operating leases 11.5 Finance leases 12.6 Weighted-average discount rate: Operating leases 5.5% Finance leases 10.5% |
Schedule of cash outflows by lease type | Six months ended June 30, Cash paid for amounts included in the measurement of lease liabilities 2024 2023 (in thousands) Operating cash outflows from operating leases $ 5,282 $ 4,858 Operating cash outflows from finance leases 2,384 2,454 Financing cash outflows from finance leases 736 598 Operating lease assets obtained in exchange for operating lease liabilities 825 23,289 Finance lease assets obtained in exchange for new finance lease liabilities — — |
Revenue (Tables)
Revenue (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Revenue | |
Schedule of revenue by discipline | Three months ended Six months ended June 30, June 30, 2024 2023 2024 2023 (in thousands) Systems $ 198,645 $ 215,174 $ 394,076 $ 410,372 Aftermarket 57,867 58,796 114,807 117,618 Total Revenue $ 256,512 $ 273,970 $ 508,883 $ 527,990 |
Schedule of revenue by geographic markets | Three months ended Six months ended June 30, June 30, 2024 2023 2024 2023 (in thousands) North America $ 34,373 $ 37,918 $ 79,876 $ 83,084 Asia Pacific 196,159 205,941 384,376 397,044 Europe 25,980 30,111 44,631 47,862 Total Revenue $ 256,512 $ 273,970 $ 508,883 $ 527,990 |
Schedule of Contract liabilities | |
Computation of Net Earnings p_2
Computation of Net Earnings per Share (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Computation of Net Earnings per Share | |
Schedule of components of net income per share | Three months ended Six months ended June 30, June 30, 2024 2023 2024 2023 (in thousands, except per share amounts) Net income available to common stockholders $ 50,866 $ 61,579 $ 102,460 $ 109,276 Weighted average shares of common stock outstanding used in computing basic income per share 32,598 32,775 32,618 32,759 Incremental options and RSUs 173 414 230 478 Weighted average shares of common stock used in computing diluted net income per share 32,771 33,189 32,848 33,237 Net income per share Basic $ 1.56 $ 1.88 $ 3.14 $ 3.34 Diluted $ 1.55 $ 1.86 $ 3.12 $ 3.29 |
Accumulated Other Comprehensi_2
Accumulated Other Comprehensive Loss (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Accumulated Other Comprehensive Loss | |
Schedule of changes in accumulated other comprehensive loss, net of tax | Foreign Defined benefit currency pension plan Total (in thousands) Balance at December 31, 2023 $ (1,956) $ 110 $ (1,846) Other comprehensive loss and pension reclassification (2,644) 10 (2,634) Balance at June 30, 2024 $ (4,600) $ 120 $ (4,480) |
Cash, cash equivalents and re_2
Cash, cash equivalents and restricted cash (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Cash, cash equivalents and restricted cash | |
Schedule of reconciliation of cash, cash equivalents and restricted cash | June 30, December 31, 2024 2023 (in thousands) Cash and cash equivalents $ 145,166 $ 167,297 Long-term restricted cash 6,651 6,654 Total cash, cash equivalents and restricted cash $ 151,817 $ 173,951 |
Inventories, net (Tables)
Inventories, net (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Inventories, net | |
Schedule of components of inventories | June 30, December 31, 2024 2023 (in thousands) Raw materials $ 220,910 $ 231,200 Work in process 40,481 45,373 Finished goods (completed systems) 21,699 29,909 Inventories, net $ 283,090 $ 306,482 |
Product Warranty (Tables)
Product Warranty (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Product Warranty | |
Schedule of product warranty liability | Six months ended June 30, 2024 2023 (in thousands) Balance at January 1 (beginning of year) $ 16,757 $ 10,487 Warranties issued during the period 5,755 5,616 Settlements made during the period (5,653) (4,834) Changes in estimate of liability for pre-existing warranties during the period (444) 1,552 Balance at June 30 (end of period) $ 16,415 $ 12,821 Amount classified as current $ 14,502 $ 10,867 Amount classified as long-term (within other long-term liabilities) 1,913 1,954 Total warranty liability $ 16,415 $ 12,821 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Fair Value Measurements | |
Schedule of Company's assets and liabilities by level within the fair value hierarchy | June 30, 2024 Fair Value Measurements Level 1 Level 2 Level 3 Total (in thousands) Assets Cash equivalents and other short-term investments: Cash equivalents (money market funds, U.S. Government Securities and Agency Investments) $ 104,958 $ — $ — $ 104,958 Short-term investments (U.S. Government Securities and Agency Investments) 402,820 — — 402,820 Mark-to-market adjustment on forward exchange contracts — (323) — (323) Total $ 507,778 $ (323) $ — $ 507,455 December 31, 2023 Fair Value Measurements Level 1 Level 2 Level 3 Total (in thousands) Assets Cash equivalents and other short-term investments: Cash equivalents (money market funds, U.S. Government Securities and Agency Investments) $ 118,278 $ — $ — $ 118,278 Short-term investments (U.S. Government Securities and Agency Investments) 339,240 — — 339,240 Total $ 457,518 $ — $ — $ 457,518 |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Details) $ in Thousands | 3 Months Ended | 6 Months Ended |
Jun. 30, 2024 USD ($) | Jun. 30, 2024 USD ($) | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Foreign exchange gains (losses) realized | $ 2,300 | $ 3,800 |
Forward exchange contracts | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Notional value of open forward contracts | $ 111,000 | 111,000 |
Unrealized gain on forward exchange contracts | $ (323) |
Stock-Based Compensation (Detai
Stock-Based Compensation (Details) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2024 | Jun. 30, 2023 | Mar. 31, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Stock-Based Compensation | |||||
Stock-based compensation expense | $ 5,500 | $ 4,700 | $ 10,200 | $ 7,900 | |
Proceeds from Employee Stock Purchase Plan purchases | 1,242 | 957 | |||
Common Stock | |||||
Stock-Based Compensation | |||||
Exercise of stock options (in shares) | 2 | ||||
Common Stock | Employee Stock Purchase Plan | |||||
Stock-Based Compensation | |||||
Proceeds from Employee Stock Purchase Plan purchases | $ 1,200 | $ 1,000 | $ 1,200 | $ 1,000 | |
Common Stock | Restricted Stock Units | |||||
Stock-Based Compensation | |||||
Exercise of stock options (in shares) | 200 | 200 | 200 | 300 |
Leases (Details)
Leases (Details) | 6 Months Ended |
Jun. 30, 2024 | |
Lease | |
Option to extend | true |
Minimum | |
Lease | |
Renewal term | 1 year |
Maximum | |
Lease | |
Renewal term | 3 years |
Leases - Operating and Finance
Leases - Operating and Finance Lease Right-of-use-assets and Related Lease Obligations (Details) - USD ($) $ in Thousands | Jun. 30, 2024 | Dec. 31, 2023 |
Leases | ||
Operating lease assets | $ 28,918 | $ 30,716 |
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] | Operating lease assets | Operating lease assets |
Finance lease assets | $ 15,989 | $ 16,632 |
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] | Finance lease assets | Finance lease assets |
Total leased assets | $ 44,907 | $ 47,348 |
Operating liabilities current | $ 4,637 | $ 4,978 |
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] | Other Liabilities, Current | Other Liabilities, Current |
Finance liabilities current | $ 1,452 | $ 1,511 |
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] | Finance liabilities current | Finance liabilities current |
Operating liabilities noncurrent | $ 24,329 | $ 25,724 |
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent |
Finance liabilities noncurrent | $ 43,004 | $ 43,674 |
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] | Finance liabilities noncurrent | Finance liabilities noncurrent |
Total lease liabilities | $ 73,422 | $ 75,887 |
Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration] | Other Liabilities, Current, Other Liabilities, Noncurrent | Other Liabilities, Current, Other Liabilities, Noncurrent |
Finance lease, accumulated depreciation | $ 46,900 | $ 46,400 |
Prepaid financing costs | $ 600 | $ 600 |
Leases - Lease Cost (Details)
Leases - Lease Cost (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Lease cost | ||||
Total operating lease cost | $ 2,685 | $ 2,614 | $ 5,282 | $ 4,858 |
Depreciation of leased assets | 321 | 318 | 643 | 637 |
Interest on lease liabilities | 1,187 | 1,223 | 2,384 | 2,454 |
Total finance lease cost | 1,508 | 1,541 | 3,027 | 3,091 |
Total lease cost | 4,193 | 4,155 | 8,309 | 7,949 |
Short-term lease and variable lease costs | 700 | 500 | 1,300 | 1,000 |
Product / services* | ||||
Lease cost | ||||
Total operating lease cost | 1,694 | 1,821 | 3,522 | 3,287 |
Research and development | ||||
Lease cost | ||||
Total operating lease cost | 203 | 137 | 326 | 243 |
Sales and marketing* | ||||
Lease cost | ||||
Total operating lease cost | 451 | 417 | 902 | 813 |
General and administrative* | ||||
Lease cost | ||||
Total operating lease cost | $ 337 | $ 239 | $ 532 | $ 515 |
Leases - Future Minimum Cash Ou
Leases - Future Minimum Cash Outflow and Weighted-average Remaining Lease Term and Discount Rate (Details) $ in Thousands | Jun. 30, 2024 USD ($) ft² | Dec. 31, 2023 USD ($) |
Future minimum lease payments finance lease | ||
2024 | $ 3,132 | |
2025 | 5,930 | |
2026 | 6,008 | |
2027 | 6,128 | |
2028 | 6,251 | |
Thereafter | 55,336 | |
Total lease payments | 82,785 | |
Less interest portion | (38,329) | |
Finance lease obligations | 44,456 | |
Future minimum lease payments operating lease | ||
2024 | 3,740 | |
2025 | 6,113 | |
2026 | 4,448 | |
2027 | 2,863 | |
2028 | 1,959 | |
Thereafter | 23,205 | |
Total lease payments | 42,328 | |
Less interest portion | (13,362) | |
Operating lease obligations | 28,966 | |
Future minimum lease payments finance and operating lease | ||
2024 | 6,872 | |
2025 | 12,043 | |
2026 | 10,456 | |
2027 | 8,991 | |
2028 | 8,210 | |
Thereafter | 78,541 | |
Total lease payments | 125,113 | |
Less interest portion | (51,691) | |
Total lease liabilities | 73,422 | $ 75,887 |
Lease term and discount rate | ||
Right of use asset | 28,918 | 30,716 |
Prepaid rent | 600 | 600 |
Operating liabilities noncurrent | $ 24,329 | $ 25,724 |
Finance lease term | 22 years | |
Operating leases -Weighted-average remaining lease term (in years) | 11 years 6 months | |
Finance leases - Weighted-average remaining lease term (in years) | 12 years 7 months 6 days | |
Operating leases - Weighted-average discount rate | 5.50% | |
Finance leases - Weighted-average discount rate | 10.50% | |
Beverly Property Owner LLC | ||
Lease term and discount rate | ||
Area of Property | ft² | 101,800 | |
Minimum | ||
Lease term and discount rate | ||
Operating lease term | 1 year | |
Maximum | ||
Lease term and discount rate | ||
Operating lease term | 16 years |
Leases - Cash Flow by Lease Typ
Leases - Cash Flow by Lease Type (Details) - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2024 | Jun. 30, 2023 | |
Leases | ||
Operating cash outflows from operating leases | $ 5,282 | $ 4,858 |
Operating cash outflows from finance leases | 2,384 | 2,454 |
Financing cash outflows from finance leases | 736 | 598 |
Operating lease assets obtained in exchange for operating lease liabilities | $ 825 | $ 23,289 |
Revenue - Revenue by discipline
Revenue - Revenue by discipline & geographical areas (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Disaggregation of Revenue | ||||
Total Revenue | $ 256,512 | $ 273,970 | $ 508,883 | $ 527,990 |
North America | ||||
Disaggregation of Revenue | ||||
Total Revenue | 34,373 | 37,918 | 79,876 | 83,084 |
Asia Pacific | ||||
Disaggregation of Revenue | ||||
Total Revenue | 196,159 | 205,941 | 384,376 | 397,044 |
Europe | ||||
Disaggregation of Revenue | ||||
Total Revenue | 25,980 | 30,111 | 44,631 | 47,862 |
Systems | ||||
Disaggregation of Revenue | ||||
Total Revenue | 198,645 | 215,174 | 394,076 | 410,372 |
Aftermarket | ||||
Disaggregation of Revenue | ||||
Total Revenue | $ 57,867 | $ 58,796 | $ 114,807 | $ 117,618 |
Revenue - Contract liabilities
Revenue - Contract liabilities (Details) - USD ($) $ in Thousands | Jun. 30, 2024 | Mar. 31, 2024 | Dec. 31, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | Dec. 31, 2022 |
Revenue | ||||||
Contract liabilities | $ 174,011 | $ 208,418 | $ 210,885 | $ 182,540 | $ 201,725 | $ 154,777 |
Revenue - Deferred revenue (Det
Revenue - Deferred revenue (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Revenue | ||||
Balance, beginning of the period | $ 208,418 | $ 201,725 | $ 210,885 | $ 154,777 |
Deferral of revenue | 19,625 | 34,977 | 55,227 | 107,556 |
Recognition of deferred revenue | (54,032) | (54,162) | (92,101) | (79,793) |
Balance, end of the period | 174,011 | $ 182,540 | 174,011 | $ 182,540 |
Reclassification from deferred revenue to refund liability | $ 4,700 | $ 4,700 |
Revenue (Details)
Revenue (Details) - USD ($) $ in Thousands | 6 Months Ended | |||||
Jun. 30, 2024 | Mar. 31, 2024 | Dec. 31, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | Dec. 31, 2022 | |
Disaggregation of Revenue | ||||||
Deferred revenue | $ 174,011 | $ 208,418 | $ 210,885 | $ 182,540 | $ 201,725 | $ 154,777 |
Short-term deferred revenue | 148,390 | 164,677 | ||||
Long-term deferred revenue | $ 25,621 | $ 46,208 | ||||
Systems | ||||||
Disaggregation of Revenue | ||||||
Payment upon shipment of the system, as a percent | 90% | |||||
Payment upon acceptance, as a percent | 10% | |||||
Systems | Minimum | ||||||
Disaggregation of Revenue | ||||||
Pre-shipment deposit, as a percent | 20% | |||||
Systems | Maximum | ||||||
Disaggregation of Revenue | ||||||
Pre-shipment deposit, as a percent | 60% | |||||
Aftermarket | Minimum | ||||||
Disaggregation of Revenue | ||||||
Payment upon delivery of parts, period | 30 days | |||||
Aftermarket | Maximum | ||||||
Disaggregation of Revenue | ||||||
Payment upon delivery of parts, period | 60 days |
Receivables and Allowances fo_2
Receivables and Allowances for Credit Losses - Trade Receivables (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | |
Jun. 30, 2024 | Jun. 30, 2024 | Jun. 30, 2023 | |
Receivables and Allowances for Credit Losses | |||
Recoveries | $ 0 | $ 500 | $ 0 |
Charge-offs | 0 | 0 | |
Provision for credit losses | $ 0 | $ 0 | $ 0 |
Computation of Net Earnings p_3
Computation of Net Earnings per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||||
Jun. 30, 2024 | Mar. 31, 2024 | Jun. 30, 2023 | Mar. 31, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Computation of Net Earnings per Share | ||||||
Net income available to common stockholders | $ 50,866 | $ 51,595 | $ 61,579 | $ 47,697 | $ 102,460 | $ 109,276 |
Weighted average shares of common stock outstanding used in computing basic income per share | 32,598 | 32,775 | 32,618 | 32,759 | ||
Incremental options and RSUs | 173 | 414 | 230 | 478 | ||
Weighted average shares of common stock used in computing diluted net income per share | 32,771 | 33,189 | 32,848 | 33,237 | ||
Net income per share | ||||||
Basic | $ 1.56 | $ 1.88 | $ 3.14 | $ 3.34 | ||
Diluted | $ 1.55 | $ 1.86 | $ 3.12 | $ 3.29 | ||
Anti-dilutive common equivalent shares excluded from calculation | 22,983 | 770 | 20,639 | 387 |
Accumulated Other Comprehensi_3
Accumulated Other Comprehensive Loss (Details) $ in Thousands | 6 Months Ended |
Jun. 30, 2024 USD ($) | |
Changes in accumulated other comprehensive (loss) income, net of tax | |
Balance at beginning of period | $ (1,846) |
Other comprehensive loss and pension reclassification | (2,634) |
Balance at end of period | (4,480) |
Foreign currency | |
Changes in accumulated other comprehensive (loss) income, net of tax | |
Balance at beginning of period | (1,956) |
Other comprehensive loss and pension reclassification | (2,644) |
Balance at end of period | (4,600) |
Defined benefit pension plan | |
Changes in accumulated other comprehensive (loss) income, net of tax | |
Balance at beginning of period | 110 |
Other comprehensive loss and pension reclassification | 10 |
Balance at end of period | $ 120 |
Cash, cash equivalents and re_3
Cash, cash equivalents and restricted cash (Details) - USD ($) $ in Thousands | Jun. 30, 2024 | Dec. 31, 2023 | Jun. 30, 2023 | Dec. 31, 2022 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract] | ||||
Cash and cash equivalents | $ 145,166 | $ 167,297 | ||
Long-term Restricted Cash | 6,651 | 6,654 | ||
Total cash, cash equivalents and restricted cash | 151,817 | $ 173,951 | $ 139,156 | $ 186,347 |
Security Deposit | 5,900 | |||
Letter of credit related to workers' compensation insurance | 700 | |||
Deposit related to customs activity | $ 100 |
Inventories, net (Details)
Inventories, net (Details) - USD ($) $ in Thousands | Jun. 30, 2024 | Dec. 31, 2023 |
Inventories, net | ||
Raw materials | $ 220,910 | $ 231,200 |
Work in process | 40,481 | 45,373 |
Finished goods (completed systems) | 21,699 | 29,909 |
Inventories, net | $ 283,090 | $ 306,482 |
Product Warranty (Details)
Product Warranty (Details) - USD ($) $ in Thousands | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | |
Product Warranty | |||
Product warranty period | 1 year | ||
Changes in standard product warranty liability | |||
Balance at beginning of year | $ 16,757 | $ 10,487 | |
Warranties issued during the period | 5,755 | 5,616 | |
Settlements made during the period | (5,653) | (4,834) | |
Changes in estimate of liability for pre-existing warranties during the period | (444) | 1,552 | |
Balance at end of period | 16,415 | 12,821 | |
Product warranty classification | |||
Amount classified as current | 14,502 | 10,867 | $ 14,098 |
Amount classified as long-term (within other long-term liabilities) | 1,913 | 1,954 | |
Total warranty liability | $ 16,415 | $ 12,821 | $ 16,757 |
Fair Value Measurements (Detail
Fair Value Measurements (Details) - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2024 | Dec. 31, 2023 | |
Fair Value Measurements | ||
Short-term investments (U.S. Government Securities and Agency Investments) | $ 403,143 | $ 338,851 |
Forward exchange contracts | ||
Fair Value Measurements | ||
Mark-to-market adjustment on forward exchange contracts | (323) | |
Level 2 | Forward exchange contracts | Estimate of fair value measurement | ||
Fair Value Measurements | ||
Mark-to-market adjustment on forward exchange contracts | (323) | |
Recurring | Estimate of fair value measurement | ||
Fair Value Measurements | ||
Total | 507,455 | |
Recurring | Forward exchange contracts | Estimate of fair value measurement | ||
Fair Value Measurements | ||
Mark-to-market adjustment on forward exchange contracts | (323) | |
Recurring | Money market funds, U.S. Government Securities and Agency Investments | Estimate of fair value measurement | ||
Fair Value Measurements | ||
Cash equivalents (money market funds, U.S. Government Securities and Agency Investments) | 104,958 | 118,278 |
Total | 457,518 | |
Recurring | U.S. Government Securities and Agency Investments | Estimate of fair value measurement | ||
Fair Value Measurements | ||
Short-term investments (U.S. Government Securities and Agency Investments) | 402,820 | 339,240 |
Recurring | Level 1 | ||
Fair Value Measurements | ||
Total | 507,778 | |
Recurring | Level 1 | Money market funds, U.S. Government Securities and Agency Investments | ||
Fair Value Measurements | ||
Cash equivalents (money market funds, U.S. Government Securities and Agency Investments) | 104,958 | 118,278 |
Total | 457,518 | |
Recurring | Level 1 | U.S. Government Securities and Agency Investments | ||
Fair Value Measurements | ||
Short-term investments (U.S. Government Securities and Agency Investments) | 402,820 | $ 339,240 |
Recurring | Level 2 | ||
Fair Value Measurements | ||
Mark-to-market adjustment on forward exchange contracts | (323) | |
Recurring | Level 2 | Forward exchange contracts | ||
Fair Value Measurements | ||
Mark-to-market adjustment on forward exchange contracts | $ (323) |
Financing Arrangements (Details
Financing Arrangements (Details) - USD ($) $ in Thousands | Jan. 30, 2015 | Jun. 30, 2024 | Dec. 31, 2023 |
Financing Arrangements | |||
Long-term finance lease obligation | $ 43,004 | $ 43,674 | |
Security deposit | 5,900 | ||
Building | |||
Financing Arrangements | |||
Proceeds from sale of corporate headquarters | $ 48,900 | ||
Lease term | 22 years | ||
Long-term finance lease obligation | 44,500 | ||
UBS Bank USA | |||
Financing Arrangements | |||
Security deposit | $ 5,900 |
Income Taxes (Details)
Income Taxes (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | |
Valuation allowance | |||||
Income tax expense | $ 6,399 | $ 3,037 | $ 13,803 | $ 8,242 | |
Increase (decrease) in income tax expense | 3,400 | ||||
Deferred tax assets, net | 55,441 | 55,441 | $ 53,428 | ||
Deferred tax assets valuation allowance | $ 11,300 | $ 11,300 | |||
Maximum | |||||
Valuation allowance | |||||
Statutory income tax rate (as a percent) | 21% | 21% |
Concentration of Risk (Details)
Concentration of Risk (Details) - customer | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | |
Revenue | Customer concentration risk | |||||
Concentration of Risk | |||||
Number of customers | 1 | 0 | 0 | 2 | |
Revenue | Customer concentration risk | First customer | |||||
Concentration of Risk | |||||
Percentage of concentration risk | 11.50% | 11.60% | |||
Revenue | Customer concentration risk | Second customer | |||||
Concentration of Risk | |||||
Percentage of concentration risk | 11.10% | ||||
Accounts Receivable | Credit concentration risk | |||||
Concentration of Risk | |||||
Number of customers | 1 | 1 | |||
Accounts Receivable | Credit concentration risk | First customer | |||||
Concentration of Risk | |||||
Percentage of concentration risk | 11.30% | 12.20% |
Share Repurchase (Details)
Share Repurchase (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions | 6 Months Ended | ||
Jun. 30, 2024 | Aug. 31, 2023 | Feb. 28, 2022 | |
Stockholders' Equity | |||
Share repurchase program common stock authorized amount | $ 200 | $ 100 | |
Number of shares repurchased | 0.3 | ||
Average cost | $ 114.07 |